Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Haemodiafiltration: current status.

Elaine Spalding1, Ken Farrington

  • 1Renal Unit, Lister Hospital, Stevenage, UK. elaine.spalding@lister.enherts-tr.co.uk

Nephron. Clinical Practice
|March 28, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rate of decline in residual kidney function and cognitive impairment in incident haemodialysis patients: A prospective, longitudinal analysis of the BISTRO trial cohort.

PloS one·2026
Same author

A new self-management engagement scale for haemodialysis patients (PRIESM CKD-HD): development and validation.

Clinical kidney journal·2026
Same author

Mental health and kidney disease.

Nature reviews. Nephrology·2026
Same author

Haemodiafiltration versus haemodialysis for kidney failure.

Lancet (London, England)·2025
Same author

Post-Hemodialysis Flow-Dependent Hepatic Function Impairment in Individuals With End Stage Kidney Disease and Chronic Inflammation.

Hemodialysis international. International Symposium on Home Hemodialysis·2025
Same author

BioImpedance Spectroscopy to maintain Renal Output: the BISTRO randomised controlled trial.

Health technology assessment (Winchester, England)·2025
Same journal

Proceedings of the 5th Annual UAB-UCSD O'Brien Center Symposium, March 4, San Diego, California.

Nephron. Clinical practice·2015
Same journal

Proceedings of the 19th International Conference on Continuous Renal Replacement Therapies, March 2-3, 2014, San Diego, California, USA.

Nephron. Clinical practice·2015
Same journal

Chronic kidney disease in disadvantaged populations.

Nephron. Clinical practice·2015
Same journal

Differential membrane expression of Toll-like receptors and intracellular cytokine induction in peripheral blood monocytes of patients with chronic kidney disease and diabetic nephropathy.

Nephron. Clinical practice·2015
Same journal

Correction of hyper- and hyponatraemia during continuous renal replacement therapy.

Nephron. Clinical practice·2015
Same journal

Ectopic expression of fatty acid-binding protein 4 in the glomerulus is associated with proteinuria and renal dysfunction.

Nephron. Clinical practice·2015
See all related articles

Haemodiafiltration, a renal replacement therapy using diffusion and convection, offers broad solute removal. Its slow adoption may increase due to technological advancements and proven safety, pending long-term clinical data.

Area of Science:

  • Nephrology
  • Renal Replacement Therapy
  • Biomedical Engineering

Background:

  • Haemodiafiltration combines diffusion and convection for enhanced solute removal.
  • Despite theoretical advantages, haemodiafiltration adoption has been limited.
  • Technological maturity and safety data are improving its prospects.

Purpose of the Study:

  • To review the current status and future potential of haemodiafiltration.
  • To highlight factors influencing the adoption of this renal replacement therapy.
  • To underscore the need for long-term clinical outcome data.

Main Methods:

  • Review of current literature on haemodiafiltration.
  • Analysis of technological advancements in renal replacement therapy.

Related Experiment Videos

  • Assessment of safety and efficacy data for haemodiafiltration.

    • Main Results:

    • Haemodiafiltration provides solute removal across a wide molecular weight range.
    • Cost-efficient online production of substitution fluid is now feasible.
    • Long-term safety of haemodiafiltration has been demonstrated.

    Conclusions:

    • Haemodiafiltration represents a theoretically superior renal replacement therapy.
    • Growing acceptance and technological progress may accelerate its uptake.
    • Further long-term clinical outcome data are essential for widespread adoption.